Carregant...

Targeting syndecan-1 in breast cancer inhibits osteoclast functions through up-regulation of osteoprotegerin

Background: Breast cancer often metastasizes into bone and leads to osteolytic lesions. The underlying mechanisms, however, are complex and not fully understood. Syndecan-1 is a proteoglycan that has various functions relevant for tumor progression including cell–cell communication and cell–matrix i...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Peggy Benad-Mehner, Stefanie Thiele, Tilman D. Rachner, Andy Göbel, Martina Rauner, Lorenz C. Hofbauer
Format: Artigo
Idioma:Inglês
Publicat: Elsevier 2014-03-01
Col·lecció:Journal of Bone Oncology
Matèries:
Accés en línia:http://www.sciencedirect.com/science/article/pii/S2212137413000651
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!